923148-87-2

Basic information

• Product Name: 4-Bromo-N,3-dimethylbenzenesulfonamide
• Synonyms: 4-Bromo-N,3-dimethylbenzenesulfonamide;N-Methyl 4-bromo-3-methylbenzenesulfonamide
• CAS NO: 923148-87-2
• Molecular Formula: C₈H₁₀BrNO₂S
• Molecular Weight: 264.1395
• Mol File: 923148-87-2.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Room temperature.
• CAS DataBase Reference: 4-Bromo-N,3-dimethylbenzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-N,3-dimethylbenzenesulfonamide(923148-87-2)
• EPA Substance Registry System: 4-Bromo-N,3-dimethylbenzenesulfonamide(923148-87-2)

Safety Data

• Hazardous Substances Data: 923148-87-2(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-Bromo-N,3-dimethylbenzenesulfonamide is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions. Its unique structure allows it to act as an intermediate in the synthesis of other organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Bromo-N,3-dimethylbenzenesulfonamide is used as a reagent for the development of new drugs. Its properties make it a valuable tool in the synthesis of potential pharmaceutical compounds, contributing to the discovery of novel therapeutic agents.
Safety Precautions:
It is important to handle 4-Bromo-N,3-dimethylbenzenesulfonamide with care, as it may cause skin and eye irritation. It should be used in a well-ventilated area and proper personal protective equipment, such as gloves and safety goggles, should be worn to minimize exposure risks.

Upstream product

• 72256-93-0 4-bromo-3-methylbenzenesulfonyl chloride 
• 74-89-5 methylamine 

Downstream Products

• 1152274-54-8 N,3-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide 
• 1612287-91-8 4-(5-aminopyrazin-2-yl)-N,3-dimethylbenzenesulfonamide 
• 1152274-62-8 (2-methyl-4-(N-methylsulfamoyl)phenyl)boronic acid 

Relevant articles and documents

New bicyclic compounds as crac channel modulators

The present invention relates to novel compounds which are inhibitors of CRAC channel activity. This invention also relates to pharmaceutical compositions containing them, process for their preparation and their use in therapy.

NAPHTHYLACETIC ACIDS

The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists or partial agonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.

MODULATORS OF ATP-BINDING CASSETTE-TRANSPORTERS

Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (""ABC"") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (""CFTR""). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.